Sheila Gujrathi's most recent trade in Janux Therapeutics Inc was a trade of 11,667 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Janux Therapeutics Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 11,667 | 11,667 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 3,750 | 118,889 | - | 0 | Common Stock | |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) | |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Purchase of securities on an exchange or from another person at price $ 2.31 per share. | 23 Dec 2024 | 130,000 | 130,000 | - | 2.3 | 300,573 | Common Stock |
| Janux Therapeutics Inc | Sheila Gujrathi | Director | Other type of transaction at price $ 0.00 per share. | 05 Nov 2024 | 4,611 | 115,139 | - | 0 | Common Stock | |
| Janux Therapeutics Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 8,350 | 8,350 | - | - | Stock Option (right to buy) | |
| Janux Therapeutics Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2024 | 2,500 | 110,528 | - | 0 | Common Stock | |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 33,000 | 33,000 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Sheila Gujrathi | Director | Other type of transaction at price $ 0.00 per share. | 29 Feb 2024 | 2,986 | 108,028 | - | 0 | Common Stock | |
| Ventyx Biosciences Inc | Gujrathi Sheila | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2024 | 80,000 | 80,000 | - | - | Stock Option (Right to Buy) | |
| Janux Therapeutics Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 15,937 | 15,937 | - | - | Stock Option (right to buy) | |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.03 per share. | 30 Mar 2023 | 100,000 | 100,000 | - | 6.0 | 603,000 | Common Stock |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Sale of securities on an exchange or to another person at price $ 33.73 per share. | 30 Mar 2023 | 100,000 | 0 | - | 33.7 | 3,373,240 | Common Stock |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Mar 2023 | 100,000 | 662,369 | - | - | Stock Option (Right to Buy) | |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 31 Dec 2022 | 32,987 | 0 | - | 0 | Common Stock | |
| Janux Therapeutics Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 21,825 | 21,825 | - | - | Stock Option (right to buy) | |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Dec 2021 | 277,941 | 277,941 | - | - | Stock Option (right to buy) | |
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | 25 Oct 2021 | 32,897 | 0 | - | - | Series A Preferred Stock | ||
| Ventyx Biosciences Inc | Sheila Gujrathi | Director | 25 Oct 2021 | 32,897 | 32,897 | - | 0 | Common Stock |